IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...

Currently, the only approved vaccine for TB is the century-old Bacillus Calmette-Guerin (BCG) vaccine, which is widely used ...

According to DOH, the BCG vaccine protects infants against tuberculosis. The letters B, C, and G stand for Bacillus ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...

Spreading easily through the air, Mycobacterium tuberculosis can establish a chronic infection in human lungs, which can turn ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the ...

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

Patna: Despite achieving more than 75% immunisation coverage for most vaccines, Bihar continues to struggle with low coverage ...

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...